Answers are grounded in this paper and cite their sources.
Purpose Research on biomedical and health technology startups in the Philippines has documented regulatory, financial, and market barriers, but little is known about how founders themselves experience, interpret, and manage the journey from ideation to commercialization. This study examines how biomedical and health technology startup founders narrate that journey in the Philippines, a resource-constrained, lower-middle-income country. Methodology: Guided by a constructivist-interpretivist paradigm, the study used narrative inquiry with eight purposively selected founders representing medical devices, pharmaceuticals, diagnostics, and digital health. The study conducted semi-structured narrative interviews, re-storied them into individual narrative profiles, member-checked them, manually coded them, and compared them through cross-narrative synthesis, retaining negative cases. Findings: The journeys were organized around five non-linear narrative thresholds: arrival or entry; building and validation under constraint; regulatory qualification; procurement and adoption; and relational reconfiguration with the systemic environment as well as, resilience and identity reconstruction. Entry was relational and often serendipitous. A problem-led orientation and commitment to identifiable beneficiaries sustained the founders. Founders validated functioning technologies through improvisation and resource combination. Regulatory qualification varied by product and venture. Founders sought clear product categorization, proportionate requirements, and predictable timelines rather than deregulation. The sharpest divergence occurred after validation, when procurement and institutional adoption enabled movement or produced delays, redirection, withdrawal, or re-entry. Financing and adoption were mutually constraining. Resilience and narrative identity formed an adaptive architecture. Resilience was characterized as individualized, team-distributed, or organizational, while identity was reconstructed in sequential, layered accumulation or continuity deepening modes. Implications: The study qualifies effectuation, resilience, narrative identity, and diffusion of innovations for resource-constrained biomedical settings. For policy, it points to aligning development funding with public procurement, proportionate regulatory pathways, pre-revenue financing, simplified administrative processes, and entrepreneurial capability building. Originality/Value: This is among the first founder-centered narrative studies of biomedical and health technology commercialization in the Philippines. It shows that the decisive challenge is not invention itself but moving viable technologies into institutional adoption and sustained public benefit. JEL codes: L26, O31, O32, I11, I18, O53.
No takes yet. Share an insight, caveat, or question.
Marquez et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: